| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.07 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.07 |